Condition
Non-small Cell Lung Cancer|Malignant Pleural Mesothelioma|Large Cell Neuroendocrine Carcinoma of the Lung
Estimated Enrollment: 120
Age Group: 18 Years to 85 Years (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label
Study ID Numbers: AK-2015-LC-1
Study First Received: April 19, 2016
Last Updated: November 18, 2016
Estimated Primary Completion Date: April 2023
Primary Outcome Measures:
Study Ia: Overall survival (OS)|Study Ib: Overall survival (OS)|Study II and III: Uptake of 68Ga-NOTA-AE105 in primary tumor lesion (dichotomized +/-)|Study Ia: Progression free survival (PFS)|Study Ib: Disease free survival (DFS)
Sponsors and Collaborators:
Rigshospitalet, Denmark
Website Link: https://ClinicalTrials.gov/show/NCT02755675
